25 Amendments of Jean-Pierre AUDY related to 2011/0402(CNS)
Amendment 178 #
Proposal for a decision
Recital 11 a (new)
Recital 11 a (new)
(11 a) International cooperation is essential to achieve the stated aims of all parts of the specific programme, and international cooperation projects targeted at countries or groups of countries on horizontal or priority issues should be implemented under each part.
Amendment 239 #
Proposal for a decision
Article 6 – paragraph 1
Article 6 – paragraph 1
1. TAfter receiving an opinion from Parliament and the Council, the Commission shall establish a European Research Council (“ERC”), which shall be the means of implementing the actions under the Part I “Excellent science” which relate to the specific objective “Strengthening Europe's science base in frontier research”. The European Research Council shall succeed the European Research Council set up by Decision 2007/134/EC.
Amendment 240 #
Proposal for a decision
Article 6 – paragraph 1
Article 6 – paragraph 1
1. The Commission shall establish a European Research Council (“ERC”), which shall be the means of implementing the actions under the Part I “Excellent science” which relate to the specific objective “Strengthening Europe's science base in frontier research”. The European Research Council shall succeed the European Research Council set up by Decision 2007/134/EC.Does not affect English version
Amendment 241 #
Proposal for a decision
Article 6 – paragraph 3 – subparagraph 2
Article 6 – paragraph 3 – subparagraph 2
The President shall be appointed by the Commission following a recruitment process involving a dedicated search committee, for a term of office limited to four years, renewable once. The recruitment process and the candidate selected shall have the approval of the Scientific Council. The Commission, after receiving an opinion from the Scientific Council Parliament, and the Council, may dismiss the ERC President if he or she does not exercise his or her duties in the best interests of the European Union.
Amendment 249 #
Proposal for a decision
Article 7 – paragraph 1 – subparagraph 2
Article 7 – paragraph 1 – subparagraph 2
The members of the Scientific Council shall be appointed by the Commission, following an independent and transparent procedure for their identification agreed with the Scientific Council, including a consultation of the scientific community and a report to the European Parliament and Council. Following an opinion from Parliament and the Council, the members of the Scientific Council may be dismissed if they do not exercise their duties in the best interests of the European Union.
Amendment 253 #
Proposal for a decision
Article 7 – paragraph 2 – subparagraph 1 – point e
Article 7 – paragraph 2 – subparagraph 1 – point e
(e) a code of conduct addressing, inter alia, the avoidance of conflict of interests., and rules governing professional secrecy and communication issues;
Amendment 267 #
Proposal for a decision
Article 13 – paragraph 1
Article 13 – paragraph 1
This Decision is addressed to the Member States and Parliament.
Amendment 329 #
Proposal for a decision
Annex 1 – point 1 – point 1.5 – paragraph 1
Annex 1 – point 1 – point 1.5 – paragraph 1
A key added value of research and innovation funded at the Union level is the possibility to disseminate and communicate results on a continent-wide scale to enhance their impact. Horizon 2020 will therefore include, under all of its specific objectives, dedicated support to dissemination (including through open access to research results), communication and dialogue actions, with a strong emphasis on communicating results to end- users, citizens, civil society organisations, industry and policy makers. To this extent, Horizon 2020 may make use of networks for information transfer. Communication activities undertaken in the context of Horizon 2020 will also seek to raise public awareness of the importance of research and innovation by means of publications, events, knowledge repositories, databases, websites or a targeted use of social media. Communication will be in the European Union’s name, and will seek to raise the profile of the ERC.
Amendment 335 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – introductory part
Annex 1 – point 2 – paragraph 2 – introductory part
The focus of international cooperation in Horizon 2020 will be on cooperation with three major country groupings: industrialised and emerging economies, enlargement and neighbourhood countries and developing countries.
Amendment 336 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – point 1
Annex 1 – point 2 – paragraph 2 – point 1
Amendment 338 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – point 2
Annex 1 – point 2 – paragraph 2 – point 2
Amendment 341 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – point 3
Annex 1 – point 2 – paragraph 2 – point 3
Amendment 342 #
Proposal for a decision
Annex 1 – point 2 – paragraph 3
Annex 1 – point 2 – paragraph 3
Amendment 348 #
Proposal for a decision
Annex 1 – point 2 – paragraph 5
Annex 1 – point 2 – paragraph 5
Amendment 350 #
Proposal for a decision
Annex 1 – point 2 – paragraph 6 – point a
Annex 1 – point 2 – paragraph 6 – point a
(a) The continuation and strengthening of the European and Developing Countries Clinical Trials Partnership (EDCTP2) on clinical trials for medical interventions against HIV, malaria and tuberculosis;
Amendment 391 #
Proposal for a decision
Annex 1 – section 1 – point 1 – point 1.1 – paragraph 1 – point 3 – indent 2
Annex 1 – section 1 – point 1 – point 1.1 – paragraph 1 – point 3 – indent 2
– regularly report to the Commission, the European Parliament and the Council on its own activities.
Amendment 399 #
Proposal for a decision
Annex 1 – section 1 – point 1 – point 1.3 – paragraph 1 – indent 3
Annex 1 – section 1 – point 1 – point 1.3 – paragraph 1 – indent 3
– appoint and dismiss the Director and the Senior Staff of the dedicated implementation structure taking into account the views of the Scientific Council;
Amendment 424 #
Proposal for a decision
Annex 1 – section 1 – point 3 – point 3.3 – paragraph 2
Annex 1 – section 1 – point 3 – point 3.3 – paragraph 2
European funding will support short term exchanges of research and innovation staff within partnerships of universities, research institutions, businesses, SMEs and other socio-economic actors among Europe, as well as between Europe and third countries to reinforce international cooperation. Specific measures will be taken with a view to strengthening the research capacities of developing countries. It will be open to research and innovation staff at all career levels, from the most junior (post-graduate) to the most senior (management), including also administrative and technical staff.
Amendment 438 #
Proposal for a decision
Annex 1 – section 1 – point 4 – point 4.1 – point 4.1.1 – introductory part
Annex 1 – section 1 – point 4 – point 4.1 – point 4.1.1 – introductory part
4.1.1. Developing new world-class research infrastructures
Amendment 444 #
Proposal for a decision
Annex 1 – section 1 – point 4 – point 4.1 – point 4.1.1 – paragraph 2 – point c a (new)
Annex 1 – section 1 – point 4 – point 4.1 – point 4.1.1 – paragraph 2 – point c a (new)
(ca) the revamping phase (for example adaptation measures to ensure that existing infrastructures meet strategic needs more effectively)
Amendment 592 #
Proposal for a decision
Annex 1 – section 3 – point 1 – paragraph 3
Annex 1 – section 3 – point 1 – paragraph 3
An increasing disease and disability burden in the context of an aging population places further demands on health and care sectors. If effective health and care is to be maintained for all ages, efforts are required to improve decision making in prevention and, treatment provision, rehabilitation and retraining, to identify and support the dissemination of best practice in the healthcare sector, and to support integrated care and the uptake of technological, organisational and social innovations empowering older persons in particular to remain active and independent. Doing so will contribute to increasing, and lengthening the duration of their physical, social, and mental well- being.
Amendment 610 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.3 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.3 – paragraph 1
Human populations are under threat from new and emerging infections (including those resulting from climate change), from drug resistance to existing pathogens and from other direct and indirect consequences of climate change. Improved methods for surveillance, early warning networks, health service organisation and preparedness campaigns are needed for the modelling of epidemics, for effective pandemic response, for responses to non infectious disease consequences of climate change, as are efforts to maintain and enhance capabilities to combat drug resistant infectious disease. In order to face up to these global challenges, the EU will, in partnership with the countries concerned, implement measures aimed at achieving concrete results in health policy, improving health care services and supporting their own research capacity.
Amendment 620 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
An improved understanding of health, disease and disease processes at all ages is needed to develop new and more effective diagnostics. Innovative and existing technologies will be developed with the goal of significantly improving disease outcomes throughso that they can be adapted to different environmental and socio-economic conditions, with the goal of ensuring earlier, more accurate diagnosis and by allowing for more patient- adapted treatment.
Amendment 628 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.8 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.8 – paragraph 1
There is a need to support the improvement of cross-cutting support technologies for drugs, biotherapy, vaccines and other therapeutic approaches, including transplantation, gene and cell therapy, including inter-disciplinary approaches (e.g. biomathematics, bioinformatics and nuclear medicine); to increase success in the drug and vaccine development process (including alternative methods to replace classical safety and effectiveness testing e.g. the development of new methods); to develop regenerative medicine approaches, including approaches based on stem cells; to develop improved medical and assistive devices and systems; to maintain and enhance our ability to combat communicable, rare, major and chronic diseases and undertake medical interventions that depend on the availability of effective antimicrobial drugs; and to develop comprehensive approaches to treat co-morbidities at all ages and avoid poly-pharmacy. These improvements will facilitate the development of new, more efficient, effective and sustainable treatments for disease and for the management of disability.
Amendment 659 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.16 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.16 – paragraph 1
Support provided will cover the full spectrum of activities from capacity- building, knowledge and technology transfer to large (including health policy), implementation, monitoring and assessment of large-scale demonstration actions, leading to scalable solutions for European and beyond.